CHNA

Loncar China BioPharma ETF
CHNA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CHNA was delisted on the 20th of October, 2023.

Back to rankings

4 hedge funds and large institutions have $90K invested in Loncar China BioPharma ETF in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18K
2
+$10K

Top Sellers

1
-$347K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$50K
2
$18K
3
$12K
4
$10K
5
–
6
–